Gerald G. Blackwell, MD, MBA, MedAxiom's president and CEO, examined how different cardiology employment models look today compared to even a decade ago. Gerald G. Blackwell, MD, MBA, MedAxiom's president and CEO, examined how different cardiology employment models look today compared to even a decade ago. | | |
|
Researchers reviewed years of data from two different Corindus systems, highlighting the consistently high clinical and technical success rates. Researchers reviewed years of data from two different Corindus systems, highlighting the consistently high clinical and technical success rates. | | |
|
The piece in question, which features a red heart-shaped balloon, has an unusual origin story, even by Banksy’s standards. The piece in question, which features a red heart-shaped balloon, has an unusual origin story, even by Banksy’s standards. | | |
|
Researchers have used a state-of-the-art microscope and advanced AI to track clotting risks in CAD patients. The goal is to spot blood clots before they even happen, ensuring patients are prescribed the right therapy for their specific needs. Researchers have used a state-of-the-art microscope and advanced AI to track clotting risks in CAD patients. The goal is to spot blood clots before they even happen, ensuring patients are prescribed the right therapy for their specific needs. | | |
|
|
These findings present additional evidence that invasive imaging tests are not necessarily more effective when it comes to evaluating patients for chest pain. These findings present additional evidence that invasive imaging tests are not necessarily more effective when it comes to evaluating patients for chest pain. | | |
|
Specialists with Duke University Medical System will participate in a free webinar focused on their experience treating heart failure with the implantable Barostim technology from CVRx. Specialists with Duke University Medical System will participate in a free webinar focused on their experience treating heart failure with the implantable Barostim technology from CVRx. | | |
|
New data out of Sweden show that using Abbott's continuous glucose monitor technology is associated with a reduced risk of being hospitalized for cardiac complications. This was true for patients with and without a history of prior heart disease. New data out of Sweden show that using Abbott's continuous glucose monitor technology is associated with a reduced risk of being hospitalized for cardiac complications. This was true for patients with and without a history of prior heart disease. | | |
|
Each valve was associated with certain benefits, but one-year outcomes were largely similar. Each valve was associated with certain benefits, but one-year outcomes were largely similar. | | |
|
|
The BATMAN technique is a safe, effective way to prevent LVOT obstruction during high-risk transcatheter mitral valve replacement, according to new data presented at SCAI 2025. The BATMAN technique is a safe, effective way to prevent LVOT obstruction during high-risk transcatheter mitral valve replacement, according to new data presented at SCAI 2025. | | |
|
Nabil Dib, MD, founder of the International Society for Cardiovascular Translational Research, details resources to help doctors and startups navigate the shift from conducting research to commercializing new products and applications. Nabil Dib, MD, founder of the International Society for Cardiovascular Translational Research, details resources to help doctors and startups navigate the shift from conducting research to commercializing new products and applications. | | |
|
SCAI and SCCT have collaborated on a new document designed to get more interventional cardiologists to embrace CT-guided PCI going forward. SCAI and SCCT have collaborated on a new document designed to get more interventional cardiologists to embrace CT-guided PCI going forward. | | |
|
|
Why do investors equate these companies with beautiful, mythical beasts? Because startups with such dazzling attributes are—or long were—rarely seen. Why do investors equate these companies with beautiful, mythical beasts? Because startups with such dazzling attributes are—or long were—rarely seen. | | |
|
Where a cautious President Biden wanted to confine American AI know-how to America, a freewheeling President Trump wants to turn it loose—at least to select friends and allies. Where a cautious President Biden wanted to confine American AI know-how to America, a freewheeling President Trump wants to turn it loose—at least to select friends and allies. | | |
|
